Earnings History Data for Kronos Bio (KRON) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Kronos Bio

Kronos Bio Inc. is a clinical-stage biopharmaceutical company. It engages in discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription. Kronos Bio Inc. is headquartered in San Mateo, Calif.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
13-11-2024	AH		KRON	Kronos Bio	53.00	-0.23	-0.26	0.00	Kronos Bio GAAP EPS of -$0.23 [11/14/2024 10:16 AM]	0.8510	-0.03 (-3.31%)	0.89	0.01 (1.24%)	0.69 - 1.60	582,658	70,000	17,198
Kronos Bio GAAP EPS of -$0.23 [11/14/2024 10:16 AM] Kronos Bio downgraded by Piper Sandler, TD Cowen [11/14/2024 11:22 AM] Kronos Bio, Inc. (KRON) Reports Q3 Loss, Tops Revenue Estimates [Nov-13-24 05:30PM] Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives [Nov-13-24 04:05PM]
08-08-2024	PM		KRON	Kronos Bio	70.00	-0.27	-0.32	0.00	Kronos Bio GAAP EPS of -$0.27, revenue of $2.69M [8/9/2024 6:52 AM]	1.04	-0.07 (-6.31%)	1.16	0.05 (4.50%)	0.69 - 1.71	77,350	90,000	5,162
Kronos Bio GAAP EPS of -$0.27, revenue of $2.69M [8/9/2024 6:52 AM]
08-08-2023	AH		KRON	Kronos Bio	99.00	-0.52	-0.50	0.00	Kronos Bio GAAP EPS of -$0.52 misses by $0.04, revenue of $1.86M beats by $0.61M [8/8/2023 5:56 PM]	1.59	-0.03 (-2.15%)	1.71	0.08 (4.91%)	1.20 - 5.50	131,573	110,000	314
Kronos Bio GAAP EPS of -$0.52 misses by $0.04, revenue of $1.86M beats by $0.61M [8/8/2023 5:56 PM]
15-03-2023	AH	4:10 PM ET (Mar 15)	KRON	Kronos Bio	92.00	-0.56	-0.55	0.00	Kronos Bio GAAP EPS of -$0.56 beats by $0.03 [3/15/2023 5:06 PM]	1.54	0.04 (2.67%)	1.50	0.0 (0.00%)	1.35 - 8.42	343,903	260,000	4,189
Kronos Bio GAAP EPS of -$0.56 beats by $0.03 [3/15/2023 5:06 PM]
04-08-2022	AH	4:05 PM ET (Aug 4)	KRON	Kronos Bio	260.00	-0.59	-0.69	0.00	Kronos Bio GAAP EPS of -$0.59 beats by $0.10 [8/4/2022 5:31 PM]	5.55	0.14 (2.49%)	5.55	0.0 (0.00%)	2.96 - 25.01	286,625	280,000	3,938
Kronos Bio GAAP EPS of -$0.59 beats by $0.10 [8/4/2022 5:31 PM] Kronos Bio Reports Recent Business Progress and Second-Quarter 2022 Financial Results [Aug-04-22 04:05PM]
04-05-2022	AH	4:05 PM ET (May 4)	KRON	Kronos Bio	284.00	-0.65	-0.65	0.00	Kronos Bio GAAP EPS of -$0.65 beats by $0.01 [5/4/2022 5:25 PM]	4.70	-0.30 (-6.00%)	5.00	0.0 (0.00%)	4.59 - 28.42	371,231	311,734	2,845
Kronos Bio GAAP EPS of -$0.65 beats by $0.01 [5/4/2022 5:25 PM] Kronos Bio Reports Recent Business Progress and First-Quarter 2022 Financial Results [May-04-22 04:05PM]
24-02-2022	AH		KRON	Kronos Bio	390.00	-1.13	-1.07	0.00	Kronos Bio GAAP EPS of -$1.13 misses by $0.03 [2/24/2022 5:33 PM]	7.15	0.13 (1.87%)	7.02	0.0 (0.00%)	6.50 - 32.18	149,099	480,000	3,754
Kronos Bio GAAP EPS of -$1.13 misses by $0.03 [2/24/2022 5:33 PM] Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2021 Financial Results [Feb-24-22 04:05PM]
09-11-2021	AH	4:05 PM ET (Nov 9)	KRON	Kronos Bio	993.00	-0.61	-0.98	0.00	Kronos Bio EPS beats by $0.40 [11/9/2021 5:05 PM]	17.52	0.34 (1.98%)	17.18	0.0 (0.00%)	15.86 - 39.60	309,600	180,000	590
Kronos Bio EPS beats by $0.40 [11/9/2021 5:05 PM] Warning: KRON is at high risk of performing badly [11/10/2021 4:45 AM] Kronos Bio Reports Recent Business Progress and Third-Quarter Financial Results [Nov-09-21 04:10PM] Kronos Bio and Tempus Announce Multi-Year Collaboration to Provide Kronos Bio With Access to Tempus Platform [Nov-08-21 04:44PM]
12-08-2021	AH	4:05 PM ET (Aug 12)	KRON	Kronos Bio, Inc.	1,135	-0.53	-0.51	0.00	Kronos Bio EPS beats by $0.09 [8/12/2021 5:12 PM]	20.17	0.70 (3.60%)	19.47	0.0 (0.00%)	18.81 - 39.60	150,120	100,000	3,411
Kronos Bio EPS beats by $0.09 [8/12/2021 5:12 PM] Kronos Bio Reports Recent Business Progress and Second Quarter Financial Results [Aug-12-21 04:05PM]
11-05-2021	AH	4:05 PM ET (May 11)	KRON	Kronos Bio, Inc.	1,440	-0.48	-0.43	0.00	Kronos Bio EPS misses by $0.05 [5/11/2021 4:44 PM]	25.38	0.90 (3.68%)	24.48	0.0 (0.00%)	19.60 - 39.60	177,751	120,000	1,085
Kronos Bio EPS misses by $0.05 [5/11/2021 4:44 PM] Kronos Bio Reports Recent Business Progress and First Quarter Financial Results and Announces Virtual R&D Day [May-11-21 04:05PM]
23-03-2021	AH		KRON	Kronos Bio, Inc.	1,654	-0.44	-1.10	0.00	Kronos Bio EPS beats by $0.09 [3/23/2021 4:58 PM]	28.28	-0.49 (-1.70%)	28.77	0.0 (0.00%)	25.50 - 39.60	537,502	290,000	194
Kronos Bio EPS beats by $0.09 [3/23/2021 4:58 PM] Kronos Bio Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial Results [Mar-23-21 04:05PM]